ArticleWorld journal of urology2025
The worldwide adoption of enhanced endoscopic imaging in diagnosis and treatment of non-muscle invasive bladder cancer (NMIBC): snapshot analysis from a global survey.
Article in World journal of urology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeTo describe the availability and use of enhanced endoscopic imaging technology as well as the factors that impact endoscopic imaging method preferences in the treatment of NMIBC.
methodsA cross-sectional online survey was prepared to capture real-life practices globally, in the endoscopic assessment and treatment of NMIBC. The survey was distributed by the Société Internationale d'Urologie (SIU) to all its members and made available in 7 languages. The data was reported quantitatively, measuring variability and central tendency.
resultsFrom the 3595 respondents (across 91 countries) 39.1% were in practice for > 20 years and 56,5% were general urologists, followed by 16.8% uro-oncologist and 8.4% endourologist. White light (WL) was the most often available endoscopic technology. Of the respondents, 60% perform < 5 TURBT/month and only 15% perform > 10 TURBT/month. 64% of the respondents had only access to WL endoscopy whereas 29% of the respondents had access to NBI, 11% to PDD and 6% to IMAGE 1S. The majority agreed on their benefit in tumor resection, detection of satellite lesions and decrease recurrence rate in pT1 tumors. Lastly, half of the respondents reported not having followed any training on the use of enhanced techniques.
conclusionOverall, there is the belief that the use of enhanced imaging techniques allows for a more complete TURBT and to prevent recurrences. Notably most respondents performed less than 5 TURBTs/month, and the highest volume is performed by general urologists. Respondents predominantly have access to WL endoscopy only, mostly due to income, work setting, and lack of training.
Indexed as
Identifiers
41236641What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.